Redmile Group, LLC Aclaris Therapeutics, Inc. Transaction History

Redmile Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $24,111 - $79,919	-11,320 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $1.37 Million - $1.99 Million	-95,500 Reduced 89.4%	11,320 $164,000
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $3,415 - $5,128	-200 Reduced 0.19%	106,820 $0
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $130,108 - $168,468	6,060 Added 6.0%	107,020 $2.64 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $2.32 Million - $2.91 Million	100,960	100,960 $2.61 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.